Xanax and Gastrointestinal motility disorder - a phase IV clinical study of FDA data

Summary:

Gastrointestinal motility disorder is reported as a side effect among people who take Xanax (alprazolam), especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years also take Synthroid, and have Depression.

The phase IV clinical study analyzes which people have Gastrointestinal motility disorder when taking Xanax. It is created by eHealthMe based on reports of 126,784 people who have side effects when taking Xanax from the FDA, and is updated regularly.

What is Xanax?

Xanax has active ingredients of alprazolam. It is often used in stress and anxiety. eHealthMe is studying from 135,347 Xanax users. Check the latest studies of Xanax.

What is Gastrointestinal motility disorder?

Gastrointestinal motility disorder (abnormal intestinal contractions) is found to be associated with 613 drugs and 721 conditions by eHealthMe. Check the latest studies of Gastrointestinal motility disorder.

On Jul, 19, 2026

126,784 people reported to have side effects when taking Xanax.
Among them, 79 people (0.06%) have Gastrointestinal motility disorder.

Could Xanax cause Gastrointestinal motility disorder?

Among these 79 people:

How long have people been on Xanax when they have Gastrointestinal motility disorder? *

What is the gender of people who have Gastrointestinal motility disorder when taking Xanax? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Gastrointestinal motility disorder when taking Xanax? *

What are other drugs people take besides Xanax? *

What are other side effects people have besides Gastrointestinal motility disorder? *

Fatigue (feeling of tiredness): 23 people, 29.11%
Nausea (feeling of having an urge to vomit): 20 people, 25.32%
Constipation: 20 people, 25.32%
Diarrhea: 14 people, 17.72%
Weight Decreased: 14 people, 17.72%
Fall: 14 people, 17.72%
Insomnia (sleeplessness): 13 people, 16.46%
Swallowing Difficulty: 12 people, 15.19%
Pain: 11 people, 13.92%
Nausea And Vomiting: 11 people, 13.92%

What are the existing conditions these people have? *

Depression: 13 people, 16.46%
High Blood Pressure: 8 people, 10.13%
Pain: 8 people, 10.13%
Constipation: 7 people, 8.86%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 7.59%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 5 people, 6.33%
Insomnia (sleeplessness): 5 people, 6.33%
Diabetes: 5 people, 6.33%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 6.33%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 5 people, 6.33%

* Approximation only. Some reports may have incomplete information.

Do you take Xanax and have Gastrointestinal motility disorder?

- Check whether Gastrointestinal motility disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xanax:

Xanax (135,347 reports)

Browse all side effects of Xanax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gastrointestinal motility disorder:

Gastrointestinal motility disorder (613 drugs)

Browse all the conditions that are associated with Gastrointestinal motility disorder:

Gastrointestinal motility disorder (721 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on alprazolam (the active ingredients of Xanax) and Xanax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.